Back
HFA Premium Access

Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

Session: Novelties in amyloid cardiomyopathy
Topic: Clinical
Speaker: Doctor V. Castiglione (Pisa, IT) Associate Professor G. Vergaro (Pisa, IT)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speakers

Doctor Vincenzo Castiglione

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)
2 presentations
0 follower

Associate Professor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)
8 presentations
0 follower

3 more presentations in this session

Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy.

Speaker: Doctor M. Maccallini (Rozzano, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights

Speaker: Doctor M. Perotto (Trieste, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Prognostic value of tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio in amyloid cardiomyopathy

Speaker: Doctor M. Maccallini (Rozzano, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Novelties in amyloid cardiomyopathy

Speakers: Doctor V. Castiglione, Associate Professor G. Vergaro, Doctor M. Maccallini, Doctor M. Perotto, Doctor M. Maccallini
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources